Products
3579 products
Page:1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
Code | Description | Unit |
---|---|---|
USP-1711100 | Vasopressin 8-L-arginine vasopressin (COLD SHIPMENT REQUIRED) | 1,7 mg |
USP-1711133 | Lypressin 8-L-lysine vasopressin (COLD SHIPMENT REQUIRED) | 2,2 mg |
USP-1711155 | Vecuronium Bromide | 50 mg |
USP-1711166 | Vecuronium Bromide Related Compound A - 3alpha, 17beta-diacetyl-oxy-2beta, 16beta-bispiperidinyl-5alpha-androstan | 25 mg |
USP-1711177 | Vecuronium Bromide Related Compound B - Piperidinium,1-[(2beta, 3alpha, 5alpha, 16beta, 17beta)-3-acetyloxy-17-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide | 15 mg |
USP-1711188 | Vecuronium Bromide Related Compound C - [Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-dihydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide] | 15 mg |
USP-1711202 | Verapamil Hydrochloride (HCl) | 200 mg |
USP-1711224 | Vecuronium Bromide Related Compound F - Piperidinium,1-[(2beta,3alpha,5alpha,16beta,17beta)-17-acetyloxy-3-hydroxy-2-(1-piperidinyl)androstan-16-yl]-1-methyl bromide | 15 mg |
USP-1711268 | Venlafaxine Hydrochloride (HCl) | 100 mg |
USP-1711279 | Venlafaxine Related Compound A - 1-(1-(4-Methoxyphenyl)-2-(methylamino)ethyl)cyclohexanol hydrochloride | 10 mg |
USP-1711304 | Verapamil Related Compound A - 3,4-Dimethoxy-alpha-[3-(methylamino)propyl]-alpha-(1-methylethyl)- benzeneacetonitrile monoHydrochloride (HCl) | 50 mg |
USP-1711406 | Verapamil Related Compound B - alpha-[2-[[2-(3,4-dimethoxyphenyl)-ethyl]methylamino]ethyl]-3,4-dimethoxy- alpha-(1-methylethyl)-benzeneacetonitrile monohydrochloride | 50 mg |
USP-1711428 | This item has been discontinued - Verapamil Related Compound D - 5,5'-[[2-(3,4)dimethoxyphenyl)ethyl]imino]bis[2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile]hydrochloride | 50 mg |
USP-1711439 | Verapamil Related Compound E - 3,4-dimethoxybenzaldehyde | 50 mg |
USP-1711440 | Verapamil Related Compound F - 3,4-Dimethoxybenzyl alcohol | 150 mg |
USP-1711461 | Verteporfin | 200 mg |
USP-1711472 | Verteporfin Related Compound A - (+/-)18-Ethenyl-4,4a-dihydro-3,4-bis(methoxycarbonyl)-4a,8,14,19-tetramethyl-23H,25H-benzo[b]prophine-9,13-dipropanoic Acid | 50 mg |
USP-1711508 | This item has been discontinued - Vidarabine | 200 mg |
USP-1712001 | Vigabatrin | 100 mg |
USP-1712012 | Vigabatrin Related Compound A - 5-vinylpyrrolidin-2-one | 50 mg |
USP-1712023 | Vigabatrin Related Compound B - (E)-2-(2-aminoethyl)bu-2-enoic acid Hydrochloride (HCl) | 30 mg |
USP-1712045 | Vigabatrin Related Compound E - 2-(2-aminobut-3-enyl)malonic acid | 30 mg |
USP-1713004 | Vinblastine Sulfate | 50 mg |
USP-1714007 | Vincristine Sulfate | 50 mg |
USP-1714018 | Vincristine Sulfate (Assay) (29.8 mg/vial) | 30 mg |
USP-1714506 | Vinorelbine Tartrate | 200 mg |
USP-1714528 | Vinorelbine Related Compound A - 4-O-Deacetylvinorelbine Tartrate | 25 mg |
USP-1714608 | Vinpocetine | 100 mg |
USP-1714619 | Vinpocetine Related Compound A - Ethyl(12RS,13aSR,13bSR)-13a-ethyl-12-hydroxy-2,3,5,6,12,13,13a,13b-octahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 30 mg |
USP-1714620 | Vinpocetine Related Compound B - Methyl(13aS,13bS)-13a-ethyl-9-methoxy-2,3,5,6,13a,13bhexahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 30 mg |
USP-1714641 | Vinpocetine Related Compound C - Ethyl(13aS,13bS)-13a-ethyl-10-methoxy-2,3,5,6,13a,13b-hexahydro-1Hindolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 30 mg |
USP-1714652 | Vinpocetine Related Compound D - Ethyl(12RS,13aRS,13bRS)-13a-ethyl-2,3,5,6,12,13,13a,13boctahydro-1H-indolo[3,2,1-de]pyrido[3,2,1-ij][1,5]naphthyridine-12-carboxylate | 30 mg |
USP-1715000 | This item has been discontinued - Viomycin Sulfate | 200 mg |
USP-1716002 | Retinyl Acetate (Vitamin A) 10 x 0.5 g ampules containing vitamin A acetate in peanut oil | 10 x 0.5 g |
USP-1717504 | Vitamin D Assay System Suitability | 1,5 g |
USP-1717708 | Vitexin | 25 mg |
USP-1718008 | Voriconazole | 100 mg |
USP-1718019 | Voriconazole Related Compound A - (2RS, 3RS)-2-(2,4-Difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | 10 mg |
USP-1718020 | Voriconazole Related Compound B - (2S,3R)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol | 10 mg |
USP-1718039 | Voriconazole Related Compound C - 1(2,-Difluorophenyl)-2-(1H-1,2,4-triazol-1-yl)ethanone | 10 mg |
USP-1718041 | Voriconazole Related Compound D - (2RS,3SR)-2-(2,4-difluorophenyl)-3-(pyrimidin-4-yl)-1-(1H-,1,2,4-triazol-1-yl)butan-2-ol | 10 mg |
USP-1718063 | Voriconazole Related Compound F - {(1RS,4SR)-7,7-Dimethyl-2-oxobicyclo[2.2.1]hept-1yl}methanesulphonic acid | 50 mg |
USP-1719000 | Warfarin | 200 mg |
USP-1719102 | Warfarin Related Compound A - 3-(o-hydroxyphenyl)-5-phenyl-2-cyclohexen-1-one | 50 mg |
USP-1719500 | Withanolide A | 15 mg |
USP-1719532 | Withanoside IV | 15 mg |
USP-1720000 | Xanthanoic Acid | 100 mg |
USP-1720203 | Xanthone | 100 mg |
USP-1720407 | Xylazine | 200 mg |
USP-1720429 | Xylazine Hydrochloride (HCl) | 200 mg |
USP-1720600 | Xylitol | 1 g |
USP-1721002 | Xylometazoline Hydrochloride (HCl) | 250 mg |
USP-1722005 | Xylose | 1 g |
USP-1724000 | Yohimbine Hydrochloride (HCl) | 200 mg |
USP-1724306 | Zalcitabine | 200 mg |
USP-1724317 | Zalcitabine Related Compound A - 2',3'-Didehydro-2',3'-dideoxycytidine | 50 mg |
USP-1724350 | Zaleplon CIV (controlled substance in USA) | 200 mg |
USP-1724361 | Zaleplon Related Compound A - (E)-N-(3-[3-(dimethylamino)acryloyl]phenyl)-N-ethylacetamide | 15 mg |
USP-1724372 | Zaleplon Related Compund B N-[3-(3-Cyanopyrazolo[1,5-alpha]pyrimidin-5-yl)phenyl]-N-ethylacetamide | 15 mg |
USP-1724408 | Ziprasidone Hydrochloride | 200 mg |
USP-1724419 | Ziprasidone Related Compound A - 3-(Piperazin-1-yl)benzo[d]isothiazole monohydrochloride | 10 mg |
USP-1724420 | Ziprasidone Related Compound B - 5-(2-(4-(Benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindoline-2,3-dione | 10 mg |
USP-1724441 | Ziprasidone Related Compound C - 5,5'-Bis(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6,6'-dichloro-3-hydroxy-3,3'-biindoline-2,2'-dione | 10 mg |
USP-1724452 | Ziprasidone Related Compound D - 3-(Benzo[d]isothiazol-3-yl)-5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one | 10 mg |
USP-1724500 | Zidovudine | 400 mg |
USP-1724521 | Zidovudine Related Compound B - 3'-chloro-3'-deoxythymidine | 25 mg |
USP-1724532 | Zidovudine Related Compound C - thymine | 100 mg |
USP-1724543 | Zidovudine Related Compound D - [1-(2-Deoxy-beta-D-ribofuranosyl)]thymine | 50 mg |
USP-1724656 | Zileuton | 150 mg |
USP-1724667 | Zileuton Related Compound A - N-(1-Benzo[b]thien-2-ylethyl)urea | 50 mg |
USP-1724678 | Zileuton Related Compound B - 2-(Benzo[b]thien-2-oyl)benzo[b]thiophene | 50 mg |
USP-1724689 | Zileuton Related Compound C - 1-Benzo[b]thien-2-ylethanone | 50 mg |
USP-1724747 | Zinc Oxide (AS) | 2 g |
USP-1724769 | Zinc Sulfate | 1 g |
USP-1724805 | Zolazepam Hydrochloride (HCl) CIII | 500 mg |
USP-1724827 | Zoledronic Acid | 150 mg |
USP-1724838 | Zoledronic Acid Related Compound A - 2-(1H-Imidazol-1-yl)acetic acid | 30 mg |
USP-1724918 | Zolpidem Related Compound A - N,N-Dimethyl-2-[7-methyl-2-p-tolylimidazo[1,2-a]pyridin-3-yl]acetamide CIV (controlled substance in USA) | 15 mg |
USP-1725003 | Zonisamide | 200 mg |
USP-1725014 | Zonisamide Related Compound A - 1,2-benzisoxazole-3-methanesulfonic acid sodium salt | 20 mg |
USP-1725036 | Zonisamide Related Compound C - N'-(benzisoxazol-3-ylmethylsulfonyl)-N,N-dimethylformimidamide | 20 mg |
USP-1727009 | Zolmitriptan | 150 mg |
USP-1727018 | Zolmitriptan R-Isomer (R)-4-({3-[2-(Dimethylamino)ethyl]indol-5-yl}methyl)oxazolidin-2-one | 20 mg |
USP-1727020 | Zolmitriptan Related Compound A - (S)-4-({3-[2-(Methylamino)ethyl]-1H-indol-5-yl}methyl)oxazolidin-2-one | 20 mg |
USP-1727031 | Zolmitriptan Related Compound B - (S)-2-Amino-3-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}propan-1-ol | 20 mg |
USP-1727053 | Zolmitriptan Related Compound D - (S)-Ethyl 3-[2-(dimethylamino)ethyl]-5-[(2-oxooxazolidin-4-yl)methyl]-1H-indole-2-carboxylate | 20 mg |
USP-1729118 | Zopiclone R-Isomer CIV (-)-(5R)-6-(5-Chloropyridin-2-yl)-7-oxo-6,7-dihydro-5H-pyrrolo{3,4-b]pyrazin-5-yl 4-methylpiperazine-1-carboxylate (controlled substance in USA) | 10 mg |
USP-1733119 | Meso-Zeaxanthin (Beta-Beta-Carotene-3,3'-diol, (3R ,3' S)-) | 5 x 30 mg |
USP-1000437 | Abacavir Related Compound D (20 mg) (N6-Cyclopropyl-9-{(1R,4S)-4-[(2,5-diamino-6-chlorpyrimidin-4-yloxy)methyl] cyclopent-2-enyl}-9H-purine-2,6-diamine) | 20 mg |
USP-1000521 | Acarbose (200 mg) (COLD SHIPMENT REQUIRED) | 200 mg |
USP-1000532 | Acarbose System Suitability Mixture (2 mg) (COLD SHIPMENT REQUIRED) | 2 mg |
USP-1003064 | Acetaminophen Related Compound F (50 mg) (p-nitrophenol) | 50 mg |
USP-1012531 | L-Alanyl-L-Alanine (200 mg) | 200 mg |
USP-1012655 | Albuterol Related Compound B (10 mg) (2-(tert-butylamino)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanone) | 10 mg |
USP-1012689 | Albuterol Related Compound E (10 mg) (2,2'-oxybis(methylene)bis{4-[2-(tert-butylamino)-1-hydroxyethyl]phenol} diacetate) | 10 mg |
USP-1012859 | Alitame - Alanine Amide Impurity (25 mg) (N-(2,2,4,4-tetramethyl-3-thietanyl)-D-alanimamide) | 25 mg |
USP-1013206 | Almond Oil (1 g) | 1 g |
USP-1013727 | Aloin (25 mg) | 25 mg |
USP-1034501 | alpha-Amylcinnamyl Acetate (500 mg) | 500 mg |
USP-1034512 | alpha-Amylcinnamyl Alcohol (500 mg) | 500 mg |